Sonic Healthcare (OTCMKTS:SKHHY) (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.
The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics. In radiology, Sonic Healthcare provides imaging services such as X-ray, ultrasound, CT and MRI scans. These services support hospitals, medical practices and community health centers by providing timely test results, second opinions and specialized diagnostic expertise.
Sonic Healthcare operates an extensive network of laboratories and imaging centers across Australia and New Zealand, Europe and North America. In Europe, the company services patients through diagnostic laboratories in Germany, Switzerland, Belgium and the United Kingdom. In the United States, Sonic Healthcare delivers pathology and clinical laboratory services through subsidiaries such as Clinical Pathology Laboratories and Suburban Laboratories.
The company places strong emphasis on quality assurance, accreditation and collaboration with medical professionals. Sonic Healthcare’s board of directors and senior management team bring together seasoned experts in healthcare administration and laboratory medicine. Through ongoing investments in technology, research partnerships and staff training, the company aims to maintain high standards of diagnostic accuracy and customer service worldwide.
